Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|79|1-2|118-128

ISSN： 0030-2414

Source： Oncology, Vol.79, Iss.1-2, 2010-11, pp. : 118-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab plus Oxaliplatin-Based Regimens for the Treatment of Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. : 431-439

Karger

Access to resources Recommend Favorite

Bevacizumab plus Irinotecan-, Fluorouracil-, and Leucovorin-Based Chemotherapy with Concomitant HAART in an HIV-Positive Patient with Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 31, Iss. 7, 2008-06 ,pp. : 394-397

Karger

Access to resources Recommend Favorite

Phase II Trial of Cetuximab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on KRAS Mutation Status (T-CORE0801)

By  

Oncology, Vol. 87, Iss. 1, 2014-06 ,pp. : 7-20

Karger

Access to resources Recommend Favorite

Immunological Effects of Bevacizumab-Based Treatment in Metastatic Colorectal Cancer

By  

Oncology, Vol. 79, Iss. 3-4, 2011-02 ,pp. : 187-196

Karger

Access to resources Recommend Favorite

Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 31-36

Karger

Access to resources Recommend Favorite